{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:12:15Z","timestamp":1791925935663,"version":"4.3.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Glanzmann thrombasthenia (GT) is a genetic bleeding disorder characterised by severely reduced\/absent platelet aggregation in response to multiple physiological agonists. The severity of bleeding in GT varies markedly, as does the emergency situations and complications encountered in patients. A number of emergency situations may occur in the context of GT, including spontaneous or provoked bleeding, such as surgery or childbirth. While general management principles apply in each of these settings, specific considerations are essential for the management of GT to avoid escalating minor bleeding events. These recommendations have been developed from a literature review and consensus from experts of the French Network for Inherited Platelet Disorders, the French Society of Emergency Medicine, representatives of patients\u2019 associations, and Orphanet to aid decision making and optimise clinical care by non-GT expert health professionals who encounter emergency situations in patients with GT.\n<\/jats:p>","DOI":"10.1186\/s13023-023-02787-2","type":"journal-article","created":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T14:02:22Z","timestamp":1688047342000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Emergency management of patients with Glanzmann thrombasthenia: consensus recommendations from the French reference center for inherited platelet disorders"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2526-8826","authenticated-orcid":false,"given":"Mathieu","family":"Fiore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine-Sophie","family":"Giraudet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Alessi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Falaise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Desprez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roseline","family":"d\u2019Oiron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Voisin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Fran\u00e7oise","family":"Hurtaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Boutroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Saultier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Lavenu-Bombled","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Bagou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Dubucs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Chauvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francine","family":"Meckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Kerbaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Giraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambra","family":"P\u00fchler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Rath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,29]]},"reference":[{"key":"2787_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1750-1172-1-10","volume":"1","author":"AT Nurden","year":"2006","unstructured":"Nurden AT. Glanzmann thrombasthenia. Orphanet J Rare Dis. 2006;1:10.","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"2787_CR2","doi-asserted-by":"publisher","first-page":"6022","DOI":"10.3390\/ijms23116022","volume":"23","author":"PK Chaudhary","year":"2022","unstructured":"Chaudhary PK, Kim S, Kim S. An insight into recent advances on platelet function in health and disease. Int J Mol Sci. 2022;23(11):6022. https:\/\/doi.org\/10.3390\/ijms23116022.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2787_CR3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1182\/blood.2021014914","volume":"140","author":"R Kaiser","year":"2022","unstructured":"Kaiser R, et al. Procoagulant platelet sentinels prevent inflammatory bleeding through GPIIBIIIA and GPVI. Blood. 2022;140(2):121\u201339.","journal-title":"Blood"},{"issue":"6","key":"2787_CR4","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1160\/TH09-04-0225","volume":"102","author":"G Di Minno","year":"2009","unstructured":"Di Minno G, et al. Glanzmann\u2019s thrombasthenia (defective platelet integrin alphaIIb-beta3): proposals for management between evidence and open issues. Thromb Haemost. 2009;102(6):1157\u201364.","journal-title":"Thromb Haemost"},{"issue":"6","key":"2787_CR5","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1055\/s-0033-1353393","volume":"39","author":"AT Nurden","year":"2013","unstructured":"Nurden AT, Pillois X, Wilcox DA. Glanzmann thrombasthenia: state of the art and future directions. Semin Thromb Hemost. 2013;39(6):642\u201355.","journal-title":"Semin Thromb Hemost"},{"issue":"8","key":"2787_CR6","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1182\/blood-2004-12-4619","volume":"106","author":"J Fang","year":"2005","unstructured":"Fang J, et al. Therapeutic expression of the platelet-specific integrin, alphaIIbbeta3, in a murine model for Glanzmann thrombasthenia. Blood. 2005;106(8):2671\u20139.","journal-title":"Blood"},{"key":"2787_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2012.151","author":"M Fiore","year":"2012","unstructured":"Fiore M, et al. Clinical utility gene card for: Glanzmann thrombasthenia. Eur J Hum Genet. 2012. https:\/\/doi.org\/10.1038\/ejhg.2012.151.","journal-title":"Eur J Hum Genet"},{"key":"2787_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.blre.2019.03.004","volume":"36","author":"AT Nurden","year":"2019","unstructured":"Nurden AT. Acquired Glanzmann thrombasthenia: from antibodies to anti-platelet drugs. Blood Rev. 2019;36:10\u201322.","journal-title":"Blood Rev"},{"issue":"4","key":"2787_CR9","doi-asserted-by":"publisher","first-page":"888","DOI":"10.3324\/haematol.2018.214239","volume":"105","author":"JP Botero","year":"2020","unstructured":"Botero JP, et al. Glanzmann thrombasthenia: genetic basis and clinical correlates. Haematologica. 2020;105(4):888\u201394.","journal-title":"Haematologica"},{"issue":"23","key":"2787_CR10","doi-asserted-by":"publisher","first-page":"5996","DOI":"10.1182\/blood-2011-07-365635","volume":"118","author":"AT Nurden","year":"2012","unstructured":"Nurden AT, et al. Glanzmann thrombasthenia: a review of ITGA2B and ITGB3 defects with emphasis on variants, phenotypic variability, and mouse models. Blood. 2012;118(23):5996\u20136005.","journal-title":"Blood"},{"issue":"2","key":"2787_CR11","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.tmrv.2016.01.001","volume":"30","author":"MC Poon","year":"2016","unstructured":"Poon MC, et al. New insights into the treatment of Glanzmann thrombasthenia. Transfus Med Rev. 2016;30(2):92\u20139.","journal-title":"Transfus Med Rev"},{"issue":"5","key":"2787_CR12","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/bjh.15409","volume":"182","author":"JD Grainger","year":"2018","unstructured":"Grainger JD, Thachil J, Will AM. How we treat the platelet glycoprotein defects; Glanzmann thrombasthenia and Bernard Soulier syndrome in children and adults. Br J Haematol. 2018;182(5):621\u201332.","journal-title":"Br J Haematol"},{"issue":"2","key":"2787_CR13","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/bjh.15087","volume":"181","author":"M Fiore","year":"2018","unstructured":"Fiore M, et al. Anti-alphaIIb beta3 immunization in Glanzmann thrombasthenia: review of literature and treatment recommendations. Br J Haematol. 2018;181(2):173\u201382.","journal-title":"Br J Haematol"},{"issue":"3","key":"2787_CR14","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1365-2141.2008.07189.x","volume":"142","author":"E Hod","year":"2008","unstructured":"Hod E, Schwartz J. Platelet transfusion refractoriness. Br J Haematol. 2008;142(3):348\u201360.","journal-title":"Br J Haematol"},{"key":"2787_CR15","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aay0203","author":"RH Lee","year":"2019","unstructured":"Lee RH, et al. Impaired hemostatic activity of healthy transfused platelets in inherited and acquired platelet disorders: mechanisms and implications. Sci Transl Med. 2019. https:\/\/doi.org\/10.1126\/scitranslmed.aay0203.","journal-title":"Sci Transl Med"},{"issue":"7","key":"2787_CR16","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.3324\/haematol.2016.160754","volume":"102","author":"S Orsini","year":"2017","unstructured":"Orsini S, et al. Bleeding risk of surgery and its prevention in patients with inherited platelet disorders. Haematologica. 2017;102(7):1192\u2013203.","journal-title":"Haematologica"},{"issue":"3","key":"2787_CR17","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1055\/s-0040-1718373","volume":"121","author":"MC Poon","year":"2021","unstructured":"Poon MC. The use of recombinant activated factor VII in patients with Glanzmann\u2019s Thrombasthenia. Thromb Haemost. 2021;121(3):332\u201340.","journal-title":"Thromb Haemost"},{"key":"2787_CR18","unstructured":"Orphanet, www.orpha.net."},{"key":"2787_CR19","doi-asserted-by":"publisher","unstructured":"Giraudet J et al. Les maladies rares aux urgences: \u00ab Orphanet Urgences \u00bb. Anesth\u00e9sie & R\u00e9animation, 2023. In Press. https:\/\/doi.org\/10.1016\/j.anrea.2023.01.006.","DOI":"10.1016\/j.anrea.2023.01.006"},{"key":"2787_CR20","unstructured":"Orphanet-Urgences, Thrombasth\u00e9nie de Glanzmann. https:\/\/www.orpha.net\/data\/patho\/Emg\/Int\/fr\/ThrombasthenieGlanzmann_FR_fr_EMG_ORPHA849.pdf, 2023."},{"key":"2787_CR21","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2147\/JBM.S271744","volume":"12","author":"N Mathews","year":"2021","unstructured":"Mathews N, Rivard GE, Bonnefoy A. Glanzmann thrombasthenia: perspectives from clinical practice on accurate diagnosis and optimal treatment strategies. J Blood Med. 2021;12:449\u201363.","journal-title":"J Blood Med"},{"issue":"5","key":"2787_CR22","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/MBC.0b013e32832b280e","volume":"20","author":"S Lison","year":"2009","unstructured":"Lison S, Spannagl M, Heindl B. Perioperative haemostatic management of Glanzmann thrombasthenia for abdominal surgery. Blood Coagul Fibrinolysis. 2009;20(5):371\u20133.","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"6","key":"2787_CR23","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1055\/s-2005-872523","volume":"217","author":"U Hennewig","year":"2005","unstructured":"Hennewig U, et al. Bleeding and surgery in children with Glanzmann thrombasthenia with and without the use of recombinant factor VII a. Klin Padiatr. 2005;217(6):365\u201370.","journal-title":"Klin Padiatr"},{"issue":"8","key":"2787_CR24","first-page":"1038","volume":"100","author":"MC Poon","year":"2015","unstructured":"Poon MC, et al. The international, prospective Glanzmann Thrombasthenia Registry: treatment and outcomes in surgical intervention. Haematologica. 2015;100(8):1038\u201344.","journal-title":"Haematologica"},{"issue":"4","key":"2787_CR25","doi-asserted-by":"publisher","first-page":"507","DOI":"10.4097\/kjae.2009.57.4.507","volume":"57","author":"JB Park","year":"2009","unstructured":"Park JB, Shin YS, Kim SH. Anesthetic experience for orthopedic surgery on a patient with Glanzmann\u2019s thrombasthenia refractory to platelet transfusion: a case report. Korean J Anesthesiol. 2009;57(4):507\u201310.","journal-title":"Korean J Anesthesiol"},{"issue":"6","key":"2787_CR26","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s00246-004-0919-7","volume":"26","author":"BT Yilmaz","year":"2005","unstructured":"Yilmaz BT, et al. Successful use of recombinant factor VIIa (NovoSeven) during cardiac surgery in a pediatric patient with Glanzmann thrombasthenia. Pediatr Cardiol. 2005;26(6):843\u20135.","journal-title":"Pediatr Cardiol"},{"issue":"2","key":"2787_CR27","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1177\/107602960300900213","volume":"9","author":"JA Bell","year":"2003","unstructured":"Bell JA, Savidge GF. Glanzmann\u2019s thrombasthenia proposed optimal management during surgery and delivery. Clin Appl Thromb Hemost. 2003;9(2):167\u201370.","journal-title":"Clin Appl Thromb Hemost"},{"issue":"6","key":"2787_CR28","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/j.1365-2516.2007.01555.x","volume":"13","author":"R Phillips","year":"2007","unstructured":"Phillips R, Richards M. Venous thrombosis in Glanzmann\u2019s thrombasthenia. Haemophilia. 2007;13(6):758\u20139.","journal-title":"Haemophilia"},{"issue":"2","key":"2787_CR29","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1046\/j.1538-7836.2003.00041.x","volume":"1","author":"H Ten Cate","year":"2003","unstructured":"Ten Cate H, et al. The role of platelets in venous thrombosis: a patient with Glanzmann\u2019s thrombasthenia and a factor V Leiden mutation suffering from deep venous thrombosis. J Thromb Haemost. 2003;1(2):394\u20135.","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2787_CR30","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1182\/blood.V90.2.888","volume":"90","author":"Y Gruel","year":"1997","unstructured":"Gruel Y, et al. Severe proximal deep vein thrombosis in a Glanzmann thrombasthenia variant successfully treated with a low molecular weight heparin. Blood. 1997;90(2):888\u201390.","journal-title":"Blood"},{"issue":"4","key":"2787_CR31","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1080\/01443610701325705","volume":"27","author":"A Anwer","year":"2007","unstructured":"Anwer A, Hanley J, Kumarendran K. Proposed management of pregnancy and labour in an inherited platelet disorder. Glanzmann\u2019s thrombasthenia J Obstet Gynaecol. 2007;27(4):421\u20133.","journal-title":"Glanzmann's thrombasthenia J Obstet Gynaecol"},{"issue":"6","key":"2787_CR32","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1055\/s-2007-993875","volume":"16","author":"DM Sherer","year":"1999","unstructured":"Sherer DM, Lerner R. Glanzmann\u2019s thrombasthenia in pregnancy: a case and review of the literature. Am J Perinatol. 1999;16(6):297\u2013301.","journal-title":"Am J Perinatol"},{"issue":"17","key":"2787_CR33","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1182\/blood.2021011595","volume":"139","author":"M Fiore","year":"2022","unstructured":"Fiore M, Sentilhes L, d\u2019Oiron R. How I manage pregnancy in women with Glanzmann thrombasthenia. Blood. 2022;139(17):2632\u201341.","journal-title":"Blood"},{"issue":"1","key":"2787_CR34","first-page":"40","volume":"61","author":"K Ito","year":"1991","unstructured":"Ito K, et al. Antibody removal therapy used successfully at delivery of a pregnant patient with Glanzmann\u2019s thrombasthenia and multiple anti-platelet antibodies. Vox Sang. 1991;61(1):40\u20136.","journal-title":"Vox Sang"},{"issue":"3","key":"2787_CR35","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1447-0756.1997.tb00839.x","volume":"23","author":"R Kashyap","year":"1997","unstructured":"Kashyap R, et al. Pregnancy in a patient of Glanzmann\u2019s thrombasthenia with antiplatelet antibodies. J Obstet Gynaecol Res. 1997;23(3):247\u201350.","journal-title":"J Obstet Gynaecol Res"},{"issue":"Suppl 1","key":"2787_CR36","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1365-2516.2011.02561.x","volume":"17","author":"FY Huq","year":"2011","unstructured":"Huq FY, Kadir RA. Management of pregnancy, labour and delivery in women with inherited bleeding disorders. Haemophilia. 2011;17(Suppl 1):20\u201330.","journal-title":"Haemophilia"},{"issue":"2","key":"2787_CR37","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ejogrb.2005.02.011","volume":"121","author":"N Leticee","year":"2005","unstructured":"Leticee N, Kaplan C, Lemery D. Pregnancy in mother with Glanzmann\u2019s thrombasthenia and isoantibody against GPIIb-IIIa: Is there a foetal risk? Eur J Obstet Gynecol Reprod Biol. 2005;121(2):139\u201342.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2787_CR38","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1750-1172-1-39","volume":"1","author":"C Kaplan","year":"2006","unstructured":"Kaplan C. Foetal and neonatal alloimmune thrombocytopaenia. Orphanet J Rare Dis. 2006;1:39.","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"2787_CR39","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.tracli.2018.07.003","volume":"25","author":"A Dupuis","year":"2018","unstructured":"Dupuis A, Gachet C. Inherited platelet disorders: management of the bleeding risk. Transfus Clin Biol. 2018;25(3):228\u201335.","journal-title":"Transfus Clin Biol"},{"issue":"5","key":"2787_CR40","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1093\/bja\/88.5.734","volume":"88","author":"S Monte","year":"2002","unstructured":"Monte S, Lyons G. Peripartum management of a patient with Glanzmann\u2019s thrombasthenia using Thrombelastograph. Br J Anaesth. 2002;88(5):734\u20138.","journal-title":"Br J Anaesth"},{"issue":"2","key":"2787_CR41","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jaapos.2005.11.017","volume":"10","author":"G Kamburoglu","year":"2006","unstructured":"Kamburoglu G, Kiratli H. Recurrent traumatic hyphema in a patient with Glanzmann thrombasthenia. J Aapos. 2006;10(2):186\u20137.","journal-title":"J Aapos"},{"issue":"9","key":"2787_CR42","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1136\/bjo.87.9.1189","volume":"87","author":"S Dinakaran","year":"2003","unstructured":"Dinakaran S, Edwards MP, Hampton KK. Acquired Glanzmann\u2019s thrombasthenia causing prolonged bleeding following phacoemulsification. Br J Ophthalmol. 2003;87(9):1189\u201390.","journal-title":"Br J Ophthalmol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02787-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-023-02787-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02787-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T14:02:41Z","timestamp":1688047361000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-023-02787-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,29]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2787"],"URL":"https:\/\/doi.org\/10.1186\/s13023-023-02787-2","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,29]]},"assertion":[{"value":"13 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"171"}}